{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:49:34Z","timestamp":1792586974468,"version":"4.5.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>This scientific commentary refers to \u2018Low-dose IL-2 fails to expand Tregs after alemtuzumab: insight into impaired immune tolerance in multiple sclerosis\u2019 by Georgieva et al. (https:\/\/doi.org\/10.1093\/brain\/awag171).<\/jats:p>","DOI":"10.1093\/brain\/awag308","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:35:20Z","timestamp":1792586120000},"source":"Crossref","is-referenced-by-count":0,"title":["Preventing autoimmunity after alemtuzumab in multiple sclerosis: regulatory T cells resist expansion"],"prefix":"10.1093","author":[{"given":"David P J","family":"Hunt","sequence":"first","affiliation":[{"name":"Institute for Neuroscience and Cardiovascular Research, University of Edinburgh , Edinburgh ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"key":"2026102108351878800_awag308-B1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/d41586-025-03193-3","article-title":"Medicine Nobel goes to scientists who revealed secrets of immune system \u2018regulation\u2019","volume":"646","author":"Naddaf","year":"2025","journal-title":"Nature"},{"key":"2026102108351878800_awag308-B2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"2026102108351878800_awag308-B3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: A randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026102108351878800_awag308-B4","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"key":"2026102108351878800_awag308-B5","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awag171","article-title":"Low-dose IL-2 fails to expand Tregs after alemtuzumab: Implications for impaired immune tolerance in multiple sclerosis","author":"Georgieva","journal-title":"Brain"},{"key":"2026102108351878800_awag308-B6","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1056\/NEJMoa0802670","article-title":"Alemtuzumab vs. interferon beta-1a in early multiple sclerosis","volume":"359","author":"CAMMS223 Trial Investigators","year":"2008","journal-title":"N Engl J Med"},{"key":"2026102108351878800_awag308-B7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1212\/WNL.0b013e318228bec5","article-title":"Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort","volume":"77","author":"Cossburn","year":"2011","journal-title":"Neurology"},{"key":"2026102108351878800_awag308-B8","doi-asserted-by":"crossref","first-page":"20200","DOI":"10.1073\/pnas.1313654110","article-title":"Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation","volume":"110","author":"Jones","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026102108351878800_awag308-B9","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/s41409-021-01277-y","article-title":"New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis","volume":"56","author":"Burt","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"2026102108351878800_awag308-B10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","article-title":"Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis","volume":"199","author":"Viglietta","year":"2004","journal-title":"J Exp Med"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awag308\/72248842\/awag308.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awag308\/72248842\/awag308.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:35:22Z","timestamp":1792586122000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/advance-article\/doi\/10.1093\/brain\/awag308\/8964685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":10,"URL":"https:\/\/doi.org\/10.1093\/brain\/awag308","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]},"article-number":"awag308"}}